INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 123 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,818 | -74.4% | 50,998 | -51.2% | 0.00% | – |
| Q4 2022 | $163,148 | +0.7% | 104,582 | +11.5% | 0.00% | – |
| Q3 2022 | $162,000 | -43.4% | 93,822 | -43.2% | 0.00% | – |
| Q2 2022 | $286,000 | -50.4% | 165,053 | +2.7% | 0.00% | – |
| Q1 2022 | $577,000 | -28.1% | 160,739 | 0.0% | 0.00% | – |
| Q4 2021 | $802,000 | -30.3% | 160,739 | 0.0% | 0.00% | – |
| Q3 2021 | $1,151,000 | +3.6% | 160,739 | +34.1% | 0.00% | – |
| Q2 2021 | $1,111,000 | -3.7% | 119,878 | -3.7% | 0.00% | – |
| Q1 2021 | $1,154,000 | +35.1% | 124,451 | +29.0% | 0.00% | – |
| Q4 2020 | $854,000 | -23.8% | 96,510 | -0.2% | 0.00% | -100.0% |
| Q3 2020 | $1,121,000 | -5.0% | 96,688 | +120.8% | 0.00% | 0.0% |
| Q2 2020 | $1,180,000 | +642.1% | 43,788 | +104.2% | 0.00% | – |
| Q1 2020 | $159,000 | +82.8% | 21,445 | -18.7% | 0.00% | – |
| Q4 2019 | $87,000 | +67.3% | 26,365 | +3.8% | 0.00% | – |
| Q3 2019 | $52,000 | -8.8% | 25,409 | +30.7% | 0.00% | – |
| Q2 2019 | $57,000 | -5.0% | 19,438 | +19.5% | 0.00% | – |
| Q1 2019 | $60,000 | -1.6% | 16,263 | +6.8% | 0.00% | – |
| Q4 2018 | $61,000 | -15.3% | 15,232 | +18.3% | 0.00% | – |
| Q3 2018 | $72,000 | +41.2% | 12,877 | 0.0% | 0.00% | – |
| Q2 2018 | $51,000 | -27.1% | 12,877 | -13.1% | 0.00% | – |
| Q1 2018 | $70,000 | -18.6% | 14,815 | -29.2% | 0.00% | – |
| Q4 2017 | $86,000 | -34.8% | 20,919 | 0.0% | 0.00% | – |
| Q3 2017 | $132,000 | +3.9% | 20,919 | +29.6% | 0.00% | – |
| Q2 2017 | $127,000 | +19.8% | 16,135 | 0.0% | 0.00% | – |
| Q1 2017 | $106,000 | -6.2% | 16,135 | -1.1% | 0.00% | – |
| Q4 2016 | $113,000 | +59.2% | 16,312 | +112.2% | 0.00% | – |
| Q3 2016 | $71,000 | -41.3% | 7,688 | -41.8% | 0.00% | – |
| Q2 2016 | $121,000 | +1.7% | 13,204 | 0.0% | 0.00% | – |
| Q1 2016 | $119,000 | +43.4% | 13,204 | +10.0% | 0.00% | – |
| Q4 2015 | $83,000 | +18.6% | 11,999 | 0.0% | 0.00% | – |
| Q3 2015 | $70,000 | -20.5% | 11,999 | +9.4% | 0.00% | – |
| Q2 2015 | $88,000 | +22.2% | 10,973 | +23.9% | 0.00% | – |
| Q1 2015 | $72,000 | -12.2% | 8,853 | 0.0% | 0.00% | – |
| Q4 2014 | $82,000 | -5.7% | 8,853 | 0.0% | 0.00% | – |
| Q3 2014 | $87,000 | – | 8,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |